Haldol-Essential Pharma Depot (Haloperidol Decanoate)

Haldol-Essential Pharma Depot is indicated for several psychiatric disorders that require stable antipsychotic coverage.

• Maintenance treatment of schizophrenia in adults.
• Management of acute psychotic episodes when oral therapy is not feasible.
• Adjunctive therapy for manic episodes of bipolar disorder.
• Treatment of Tourette syndrome symptoms.
• Situations where adherence to daily oral medication is challenging.

Side effects of Haldol-Essential Pharma Depot vary in frequency and severity.

Common

• Sedation or drowsiness.
• Extrapyramidal symptoms such as tremor or rigidity.
• Weight gain or increased appetite.
• Dry mouth and constipation.
• Orthostatic hypotension.
• Elevated prolactin levels.

Serious

• Neuroleptic malignant syndrome.
• Tardive dyskinesia.
• Severe cardiac arrhythmias.
• Hyperglycemia or new‑onset diabetes.
• Persistent severe extrapyramidal reactions.

Before initiating Haldol-Essential Pharma Depot, clinicians should evaluate several safety considerations.

• Assess cardiovascular history, especially for QT prolongation risk.
• Monitor for signs of metabolic disturbances, including glucose and lipid changes.
• Evaluate baseline movement disorders; patients with Parkinsonian features may be more vulnerable.
• Use caution in patients with a history of seizures or neuroleptic malignant syndrome.
• Discuss pregnancy and lactation status; the safety profile is not well established.
• Regularly review liver and renal function, adjusting care as needed.

Drug interactions can affect the efficacy and safety of Haldol-Essential Pharma Depot.

Avoid

• Other dopamine antagonists or high‑potency antipsychotics, which may increase extrapyramidal risk.
• Medications that prolong the QT interval, such as certain antiarrhythmics and macrolide antibiotics.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin) that can raise haloperidol levels.

Use with caution

• CYP3A4 inducers (e.g., carbamazepine, rifampin) that may reduce drug exposure.
• CNS depressants, including benzodiazepines and alcohol, which can enhance sedation.
• Anticholinergic agents that may mask extrapyramidal symptoms.
• Lithium, due to potential additive neurotoxic effects.